Leveljump Healthcare Corp. (JMPHF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 9.65 Million CAD | 135.56% |
| 2022 | 4.09 Million CAD | 661.83% |
| 2021 | -729.68 Thousand CAD | 6.99% |
| 2020 | -784.52 Thousand CAD | -758.9% |
| 2019 | 119.06 Thousand CAD | -54.17% |
| 2018 | 259.78 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 8.76 Million CAD | -7.56% |
| 2024 Q1 | 9.48 Million CAD | -1.79% |
| 2023 Q1 | 5.01 Million CAD | 22.37% |
| 2023 FY | 9.65 Million CAD | 135.56% |
| 2023 Q2 | 4.19 Million USD | -16.45% |
| 2023 Q3 | 4.24 Million USD | 1.2% |
| 2023 Q4 | 9.65 Million CAD | 127.68% |
| 2022 FY | 4.09 Million CAD | 661.83% |
| 2022 Q4 | 4.09 Million CAD | 43.58% |
| 2022 Q3 | 2.85 Million CAD | 24.47% |
| 2022 Q2 | 2.29 Million CAD | -32.56% |
| 2022 Q1 | 3.4 Million CAD | 566.13% |
| 2021 Q1 | -491.71 Thousand CAD | 36.13% |
| 2021 FY | -729.68 Thousand CAD | 6.99% |
| 2021 Q4 | -729.68 Thousand CAD | 34.36% |
| 2021 Q3 | -1.11 Million CAD | 23.54% |
| 2021 Q2 | -1.45 Million CAD | -195.69% |
| 2020 FY | -784.52 Thousand CAD | -758.9% |
| 2020 Q3 | 173.75 Thousand CAD | 6.69% |
| 2020 Q2 | 162.85 Thousand CAD | 0.0% |
| 2020 Q1 | - CAD | -100.0% |
| 2020 Q4 | -769.89 Thousand CAD | -543.09% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q4 | 212.45 Thousand CAD | 0.0% |
| 2019 FY | 119.06 Thousand CAD | -54.17% |
| 2018 FY | 259.78 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | -337.763% |
| Arrayit Corporation | 1.05 Million USD | -814.858% |
| Atlantic International Corp. | 236.49 Thousand USD | -3983.392% |
| Biocept, Inc. | -788 Thousand USD | 1325.515% |
| Bioqual, Inc. | -12 Million USD | 180.428% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | -42369.141% |
| DermTech, Inc. | 17.65 Million USD | 45.295% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 101.687% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 230.909% |
| iMD Companies, Inc. | 1.11 Million USD | -765.394% |
| IDenta Corp. | 524.85 Thousand USD | -1739.958% |
| Interpace Biosciences, Inc. | 7.69 Million USD | -25.514% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 35930.58% |
| InVitro International | -313.14 Thousand USD | 3183.923% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | -516.704% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 1354526.087% |
| Medical Imaging Corp. | 3.79 Million USD | -154.741% |
| NovelStem International Corp. | 3.52 Million USD | -174.229% |
| Optigenex Inc. | 8.93 Million USD | -8.094% |
| PharmChem, Inc. | -1.49 Million USD | 746.211% |
| Proteome Sciences plc | 14.57 Million USD | 33.735% |
| Response Genetics, Inc | -13.08 Million USD | 173.797% |
| Rennova Health, Inc. | 14.82 Million USD | 34.881% |
| RushNet, Inc. | 4.8 Million USD | -101.153% |
| ScreenPro Security Inc. | 135.58 Thousand USD | -7022.302% |
| Stella Diagnostics Inc. | 6.19 Million USD | -55.934% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | -441.194% |
| Todos Medical Ltd. | 38.31 Million USD | 74.795% |